Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment
To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents' preferences for their daughters' uptake, and which trade-offs parents are willing to...
Gespeichert in:
| Veröffentlicht in: | BMC public health 2014-05, Vol.14 (1), p.454-454, Article 454 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 454 |
|---|---|
| container_issue | 1 |
| container_start_page | 454 |
| container_title | BMC public health |
| container_volume | 14 |
| creator | Hofman, Robine de Bekker-Grob, Esther W Raat, Hein Helmerhorst, Theo J M van Ballegooijen, Marjolein Korfage, Ida J |
| description | To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents' preferences for their daughters' uptake, and which trade-offs parents are willing to make between these aspects.
A discrete choice experiment (DCE) was conducted among parents with a daughter aged 10-12 years. Panel mixed logit regression models were used to determine parents' preferences for vaccination. Trade-offs were quantified between four vaccination programme aspects: degree of protection against cervical cancer, duration of protection, risk of serious side-effects, and age of vaccination.
Total response rate was 302/983 (31%). All aspects influenced respondents' preferences for HPV vaccination (p |
| doi_str_mv | 10.1186/1471-2458-14-454 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4047770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A539592057</galeid><sourcerecordid>A539592057</sourcerecordid><originalsourceid>FETCH-LOGICAL-b584t-5fcaa9c0a5d59dc31abdad1bc5acc289bc66ab51aa1791b92af77df801b6a57d3</originalsourceid><addsrcrecordid>eNqNUs-L1TAQLqK46-rdkwQ86KVr0iYvrYeF5eEvWNSDnsM0SdssbVKT9qHgH--Utz73yQoSSIbJN998fDNZ9pTRc8aqzSvGJcsLLqqc8ZwLfi87PaTu34pPskcpXVPKZCWKh9lJwatKVBt2mv38DNH6Ob0gU7StxVjbRNoQyQ60dh5m5ztiYOn62cZEoAPn00z6ZQRPJpjcMIQRdi4uiThP5t6SjxbvOIA36TUBYlzS0c6W6D44bYn9PtnoRuz6OHvQwpDsk5v3LPv69s2X7fv86tO7D9vLq7wRFZ9z0WqAWlMQRtRGlwwaA4Y1WqDEoqobvdlAIxgAkzVr6gJaKU1bUdZsQEhTnmUXe95paUZrNLaOMKgJVUD8oQI4dfzjXa-6sFOcciklRYLtnqBx4R8Exz86jGp1X63uY6RwOMjy8kZGDN8Wm2Y1ojV2QKdsWJJigtOiFEKU_wEtOZcFLgFCn_8FvQ5L9OjnipJMVKUs_6A6GKxyvg2oU6-k6lKUtagLKiSizu9A4TF2dDp42zrMHxXQfYGOISXcoIMnjKp1Re9y4dntYRwKfu9k-QsxV-Qo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1537158373</pqid></control><display><type>article</type><title>Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink (Online service)</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><source>Springer Nature OA Free Journals</source><creator>Hofman, Robine ; de Bekker-Grob, Esther W ; Raat, Hein ; Helmerhorst, Theo J M ; van Ballegooijen, Marjolein ; Korfage, Ida J</creator><creatorcontrib>Hofman, Robine ; de Bekker-Grob, Esther W ; Raat, Hein ; Helmerhorst, Theo J M ; van Ballegooijen, Marjolein ; Korfage, Ida J</creatorcontrib><description>To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents' preferences for their daughters' uptake, and which trade-offs parents are willing to make between these aspects.
A discrete choice experiment (DCE) was conducted among parents with a daughter aged 10-12 years. Panel mixed logit regression models were used to determine parents' preferences for vaccination. Trade-offs were quantified between four vaccination programme aspects: degree of protection against cervical cancer, duration of protection, risk of serious side-effects, and age of vaccination.
Total response rate was 302/983 (31%). All aspects influenced respondents' preferences for HPV vaccination (p < 0.05). Respondents preferred vaccination at age 14 years instead of at a younger age. Respondents were willing to trade-off 11% of the degree of protection to obtain life-time protection instead of 25 years. To obtain a vaccination with a risk of serious side-effects of 1/750,000 instead of 1/150,000, respondents were willing to trade-off 21%.
Uptake may rise if the age ranges for free HPV vaccinations are broadened. Based on the trade-offs parents were willing to make, we conclude that uptake would increase if new evidence indicated outcomes are better than are currently understood, particularly for degree and duration of protection.</description><identifier>ISSN: 1471-2458</identifier><identifier>EISSN: 1471-2458</identifier><identifier>DOI: 10.1186/1471-2458-14-454</identifier><identifier>PMID: 24885861</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adolescent Health Services ; Adult ; Cervical cancer ; Child ; Choice Behavior ; Female ; Human papillomavirus ; Humans ; Immunization ; Male ; Netherlands ; Nuclear Family ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - administration & dosage ; Parents ; Studies ; Uterine Cervical Neoplasms - prevention & control ; Vaccines</subject><ispartof>BMC public health, 2014-05, Vol.14 (1), p.454-454, Article 454</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Hofman et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Copyright © 2014 Hofman et al.; licensee BioMed Central Ltd. 2014 Hofman et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b584t-5fcaa9c0a5d59dc31abdad1bc5acc289bc66ab51aa1791b92af77df801b6a57d3</citedby><cites>FETCH-LOGICAL-b584t-5fcaa9c0a5d59dc31abdad1bc5acc289bc66ab51aa1791b92af77df801b6a57d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047770/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047770/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24885861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hofman, Robine</creatorcontrib><creatorcontrib>de Bekker-Grob, Esther W</creatorcontrib><creatorcontrib>Raat, Hein</creatorcontrib><creatorcontrib>Helmerhorst, Theo J M</creatorcontrib><creatorcontrib>van Ballegooijen, Marjolein</creatorcontrib><creatorcontrib>Korfage, Ida J</creatorcontrib><title>Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment</title><title>BMC public health</title><addtitle>BMC Public Health</addtitle><description>To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents' preferences for their daughters' uptake, and which trade-offs parents are willing to make between these aspects.
A discrete choice experiment (DCE) was conducted among parents with a daughter aged 10-12 years. Panel mixed logit regression models were used to determine parents' preferences for vaccination. Trade-offs were quantified between four vaccination programme aspects: degree of protection against cervical cancer, duration of protection, risk of serious side-effects, and age of vaccination.
Total response rate was 302/983 (31%). All aspects influenced respondents' preferences for HPV vaccination (p < 0.05). Respondents preferred vaccination at age 14 years instead of at a younger age. Respondents were willing to trade-off 11% of the degree of protection to obtain life-time protection instead of 25 years. To obtain a vaccination with a risk of serious side-effects of 1/750,000 instead of 1/150,000, respondents were willing to trade-off 21%.
Uptake may rise if the age ranges for free HPV vaccinations are broadened. Based on the trade-offs parents were willing to make, we conclude that uptake would increase if new evidence indicated outcomes are better than are currently understood, particularly for degree and duration of protection.</description><subject>Adolescent</subject><subject>Adolescent Health Services</subject><subject>Adult</subject><subject>Cervical cancer</subject><subject>Child</subject><subject>Choice Behavior</subject><subject>Female</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Netherlands</subject><subject>Nuclear Family</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines - administration & dosage</subject><subject>Parents</subject><subject>Studies</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>Vaccines</subject><issn>1471-2458</issn><issn>1471-2458</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNUs-L1TAQLqK46-rdkwQ86KVr0iYvrYeF5eEvWNSDnsM0SdssbVKT9qHgH--Utz73yQoSSIbJN998fDNZ9pTRc8aqzSvGJcsLLqqc8ZwLfi87PaTu34pPskcpXVPKZCWKh9lJwatKVBt2mv38DNH6Ob0gU7StxVjbRNoQyQ60dh5m5ztiYOn62cZEoAPn00z6ZQRPJpjcMIQRdi4uiThP5t6SjxbvOIA36TUBYlzS0c6W6D44bYn9PtnoRuz6OHvQwpDsk5v3LPv69s2X7fv86tO7D9vLq7wRFZ9z0WqAWlMQRtRGlwwaA4Y1WqDEoqobvdlAIxgAkzVr6gJaKU1bUdZsQEhTnmUXe95paUZrNLaOMKgJVUD8oQI4dfzjXa-6sFOcciklRYLtnqBx4R8Exz86jGp1X63uY6RwOMjy8kZGDN8Wm2Y1ojV2QKdsWJJigtOiFEKU_wEtOZcFLgFCn_8FvQ5L9OjnipJMVKUs_6A6GKxyvg2oU6-k6lKUtagLKiSizu9A4TF2dDp42zrMHxXQfYGOISXcoIMnjKp1Re9y4dntYRwKfu9k-QsxV-Qo</recordid><startdate>20140515</startdate><enddate>20140515</enddate><creator>Hofman, Robine</creator><creator>de Bekker-Grob, Esther W</creator><creator>Raat, Hein</creator><creator>Helmerhorst, Theo J M</creator><creator>van Ballegooijen, Marjolein</creator><creator>Korfage, Ida J</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>7U1</scope><scope>7U2</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20140515</creationdate><title>Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment</title><author>Hofman, Robine ; de Bekker-Grob, Esther W ; Raat, Hein ; Helmerhorst, Theo J M ; van Ballegooijen, Marjolein ; Korfage, Ida J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b584t-5fcaa9c0a5d59dc31abdad1bc5acc289bc66ab51aa1791b92af77df801b6a57d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adolescent Health Services</topic><topic>Adult</topic><topic>Cervical cancer</topic><topic>Child</topic><topic>Choice Behavior</topic><topic>Female</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Netherlands</topic><topic>Nuclear Family</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines - administration & dosage</topic><topic>Parents</topic><topic>Studies</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hofman, Robine</creatorcontrib><creatorcontrib>de Bekker-Grob, Esther W</creatorcontrib><creatorcontrib>Raat, Hein</creatorcontrib><creatorcontrib>Helmerhorst, Theo J M</creatorcontrib><creatorcontrib>van Ballegooijen, Marjolein</creatorcontrib><creatorcontrib>Korfage, Ida J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Engineering Database</collection><collection>Environmental Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>Risk Abstracts</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hofman, Robine</au><au>de Bekker-Grob, Esther W</au><au>Raat, Hein</au><au>Helmerhorst, Theo J M</au><au>van Ballegooijen, Marjolein</au><au>Korfage, Ida J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment</atitle><jtitle>BMC public health</jtitle><addtitle>BMC Public Health</addtitle><date>2014-05-15</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>454</spage><epage>454</epage><pages>454-454</pages><artnum>454</artnum><issn>1471-2458</issn><eissn>1471-2458</eissn><abstract>To generate knowledge about potential improvements to human papillomavirus (HPV) vaccination information and organization strategies, we assessed how aspects of HPV vaccination are associated with parents' preferences for their daughters' uptake, and which trade-offs parents are willing to make between these aspects.
A discrete choice experiment (DCE) was conducted among parents with a daughter aged 10-12 years. Panel mixed logit regression models were used to determine parents' preferences for vaccination. Trade-offs were quantified between four vaccination programme aspects: degree of protection against cervical cancer, duration of protection, risk of serious side-effects, and age of vaccination.
Total response rate was 302/983 (31%). All aspects influenced respondents' preferences for HPV vaccination (p < 0.05). Respondents preferred vaccination at age 14 years instead of at a younger age. Respondents were willing to trade-off 11% of the degree of protection to obtain life-time protection instead of 25 years. To obtain a vaccination with a risk of serious side-effects of 1/750,000 instead of 1/150,000, respondents were willing to trade-off 21%.
Uptake may rise if the age ranges for free HPV vaccinations are broadened. Based on the trade-offs parents were willing to make, we conclude that uptake would increase if new evidence indicated outcomes are better than are currently understood, particularly for degree and duration of protection.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24885861</pmid><doi>10.1186/1471-2458-14-454</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-2458 |
| ispartof | BMC public health, 2014-05, Vol.14 (1), p.454-454, Article 454 |
| issn | 1471-2458 1471-2458 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4047770 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerLink (Online service); PubMed Central; EZB Electronic Journals Library; Springer Nature OA Free Journals |
| subjects | Adolescent Adolescent Health Services Adult Cervical cancer Child Choice Behavior Female Human papillomavirus Humans Immunization Male Netherlands Nuclear Family Papillomavirus Infections - prevention & control Papillomavirus Vaccines - administration & dosage Parents Studies Uterine Cervical Neoplasms - prevention & control Vaccines |
| title | Parents' preferences for vaccinating daughters against human papillomavirus in the Netherlands: a discrete choice experiment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parents'%20preferences%20for%20vaccinating%20daughters%20against%20human%20papillomavirus%20in%20the%20Netherlands:%20a%20discrete%20choice%20experiment&rft.jtitle=BMC%20public%20health&rft.au=Hofman,%20Robine&rft.date=2014-05-15&rft.volume=14&rft.issue=1&rft.spage=454&rft.epage=454&rft.pages=454-454&rft.artnum=454&rft.issn=1471-2458&rft.eissn=1471-2458&rft_id=info:doi/10.1186/1471-2458-14-454&rft_dat=%3Cgale_pubme%3EA539592057%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1537158373&rft_id=info:pmid/24885861&rft_galeid=A539592057&rfr_iscdi=true |